An Epigenetic LINE-1-Based Mechanism in Cancer
Abstract
:1. Introduction: The “War on Cancer” and Its Legacy
2. The Epigenetic Impact of Reverse Transcriptase (RT) Inhibitors on Cancer
3. RT Inhibitors Induce Epigenetic Alterations in the Nuclear Architecture of Cancer Cells
4. The Epigenetic Reshaping of the Cancer Genome: A Model
5. Bursts of LINE-1 Expression in the Early Genesis of Metastasis
6. The Entangled Worlds of Embryos and Cancer: Cancers Stem from the Reactivation of the Embryonic Epigenetic Circuits
Author Contributions
Funding
Conflicts of Interest
References
- Hanahan, D.; Weinberg, R.A. The Hallmarks of Cancer. Cell 2000, 100, 57–70. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Hanahan, D.; Weinberg, R.A. Hallmarks of Cancer: The next Generation. Cell 2011, 144, 646–674. [Google Scholar] [CrossRef] [Green Version]
- Hanahan, D. Rethinking the War on Cancer. Lancet 2014, 383, 558–563. [Google Scholar] [CrossRef] [PubMed]
- Hanahan, D. Hallmarks of Cancer: New Dimensions. Cancer Discov. 2022, 12, 31–46. [Google Scholar] [CrossRef] [PubMed]
- Haber, D.A.; Gray, N.S.; Baselga, J. The Evolving War on Cancer. Cell 2011, 145, 19–24. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Kratzer, T.B.; Siegel, R.L.; Miller, K.D.; Sung, H.; Islami, F.; Jemal, A. Progress Against Cancer Mortality 50 Years After Passage of the National Cancer Act. JAMA Oncol. 2022, 8, 156. [Google Scholar] [CrossRef]
- Heng, J.; Heng, H.H. Genome Chaos, Information Creation, and Cancer Emergence: Searching for New Frameworks on the 50th Anniversary of the “War on Cancer”. Genes 2021, 13, 101. [Google Scholar] [CrossRef] [PubMed]
- Oronsky, B.; Carter, C.A.; Mackie, V.; Scicinski, J.; Oronsky, A.; Oronsky, N.; Caroen, S.; Parker, C.; Lybeck, M.; Reid, T. The War on Cancer: A Military Perspective. Front. Oncol. 2015, 4, 387. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Erenpreisa, J.; Salmina, K.; Anatskaya, O.; Cragg, M.S. Paradoxes of Cancer: Survival at the Brink. Semin. Cancer Biol. 2022, 81, 119–131. [Google Scholar] [CrossRef]
- Nurse, P. Biology Must Generate Ideas as Well as Data. Nature 2021, 597, 305. [Google Scholar] [CrossRef]
- Kennedy, S.R.; Zhang, Y.; Risques, R.A. Cancer-Associated Mutations but No Cancer: Insights into the Early Steps of Carcinogenesis and Implications for Early Cancer Detection. Trends Cancer 2019, 5, 531–540. [Google Scholar] [CrossRef] [PubMed]
- Jaiswal, S.; Fontanillas, P.; Flannick, J.; Manning, A.; Grauman, P.V.; Mar, B.G.; Lindsley, R.C.; Mermel, C.H.; Burtt, N.; Chavez, A.; et al. Age-Related Clonal Hematopoiesis Associated with Adverse Outcomes. N. Engl. J. Med. 2014, 371, 2488–2498. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Xie, M.; Lu, C.; Wang, J.; McLellan, M.D.; Johnson, K.J.; Wendl, M.C.; McMichael, J.F.; Schmidt, H.K.; Yellapantula, V.; Miller, C.A.; et al. Age-Related Mutations Associated with Clonal Hematopoietic Expansion and Malignancies. Nat. Med. 2014, 20, 1472–1478. [Google Scholar] [CrossRef]
- Martincorena, I.; Roshan, A.; Gerstung, M.; Ellis, P.; Van Loo, P.; McLaren, S.; Wedge, D.C.; Fullam, A.; Alexandrov, L.B.; Tubio, J.M.; et al. High Burden and Pervasive Positive Selection of Somatic Mutations in Normal Human Skin. Science 2015, 348, 880–886. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Martincorena, I.; Fowler, J.C.; Wabik, A.; Lawson, A.R.J.; Abascal, F.; Hall, M.W.J.; Cagan, A.; Murai, K.; Mahbubani, K.; Stratton, M.R.; et al. Somatic Mutant Clones Colonize the Human Esophagus with Age. Science 2018, 362, 911–917. [Google Scholar] [CrossRef] [Green Version]
- Yokoyama, A.; Kakiuchi, N.; Yoshizato, T.; Nannya, Y.; Suzuki, H.; Takeuchi, Y.; Shiozawa, Y.; Sato, Y.; Aoki, K.; Kim, S.K.; et al. Age-Related Remodelling of Oesophageal Epithelia by Mutated Cancer Drivers. Nature 2019, 565, 312–317. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Lee-Six, H.; Olafsson, S.; Ellis, P.; Osborne, R.J.; Sanders, M.A.; Moore, L.; Georgakopoulos, N.; Torrente, F.; Noorani, A.; Goddard, M.; et al. The Landscape of Somatic Mutation in Normal Colorectal Epithelial Cells. Nature 2019, 574, 532–537. [Google Scholar] [CrossRef]
- Keogh, M.J.; Wei, W.; Aryaman, J.; Walker, L.; van den Ameele, J.; Coxhead, J.; Wilson, I.; Bashton, M.; Beck, J.; West, J.; et al. High Prevalence of Focal and Multi-Focal Somatic Genetic Variants in the Human Brain. Nat. Commun. 2018, 9, 4257. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Yizhak, K.; Aguet, F.; Kim, J.; Hess, J.M.; Kübler, K.; Grimsby, J.; Frazer, R.; Zhang, H.; Haradhvala, N.J.; Rosebrock, D.; et al. RNA Sequence Analysis Reveals Macroscopic Somatic Clonal Expansion across Normal Tissues. Science 2019, 364, eaaw0726. [Google Scholar] [CrossRef] [PubMed]
- de Magalhães, J.P. Every Gene Can (and Possibly Will) Be Associated with Cancer. Trends Genet. 2022, 38, 216–217. [Google Scholar] [CrossRef]
- Mohapatra, S.; Winkle, M.; Ton, A.N.; Nguyen, D.; Calin, G.A. The Role of Noncoding RNAs in Chromosomal Instability in Cancer. J. Pharmacol. Exp. Ther. 2022. [Google Scholar] [CrossRef]
- Mitelman, F.; Johansson, B.; Mertens, F. The Impact of Translocations and Gene Fusions on Cancer Causation. Nat. Rev. Cancer 2007, 7, 233–245. [Google Scholar] [CrossRef] [PubMed]
- Schukken, K.M.; Foijer, F. CIN and Aneuploidy: Different Concepts, Different Consequences. BioEssays 2018, 40, 1700147. [Google Scholar] [CrossRef] [PubMed]
- Patel, S.A.; Vanharanta, S. Epigenetic Determinants of Metastasis. Mol. Oncol. 2017, 11, 79–96. [Google Scholar] [CrossRef] [Green Version]
- Banerjee, R.; Smith, J.; Eccles, M.R.; Weeks, R.J.; Chatterjee, A. Epigenetic Basis and Targeting of Cancer Metastasis. Trends Cancer 2022, 8, 226–241. [Google Scholar] [CrossRef]
- Hendrix, M.J.C.; Seftor, E.A.; Seftor, R.E.B.; Kasemeier-Kulesa, J.; Kulesa, P.M.; Postovit, L.-M. Reprogramming Metastatic Tumour Cells with Embryonic Microenvironments. Nat. Rev. Cancer 2007, 7, 246–255. [Google Scholar] [CrossRef] [PubMed]
- Nebbioso, A.; Tambaro, F.P.; Dell’Aversana, C.; Altucci, L. Cancer Epigenetics: Moving Forward. PLoS Genet. 2018, 14, e1007362. [Google Scholar] [CrossRef] [Green Version]
- Maher, B. ENCODE: The Human Encyclopaedia. Nature 2012, 489, 46–48. [Google Scholar] [CrossRef] [Green Version]
- Stunnenberg, H.G.; Hirst, M. The International Human Epigenome Consortium: A Blueprint for Scientific Collaboration and Discovery. Cell 2016, 167, 1897. [Google Scholar] [CrossRef] [Green Version]
- The ENCODE Project Consortium An Integrated Encyclopedia of DNA Elements in the Human Genome. Nature 2012, 489, 57–74. [CrossRef]
- Flavahan, W.A.; Gaskell, E.; Bernstein, B.E. Epigenetic Plasticity and the Hallmarks of Cancer. Science 2017, 357, eaal2380. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Chatterjee, A.; Rodger, E.J.; Eccles, M.R. Epigenetic Drivers of Tumourigenesis and Cancer Metastasis. Semin. Cancer Biol. 2018, 51, 149–159. [Google Scholar] [CrossRef]
- Lu, Y.; Chan, Y.-T.; Tan, H.-Y.; Li, S.; Wang, N.; Feng, Y. Epigenetic Regulation in Human Cancer: The Potential Role of Epi-Drug in Cancer Therapy. Mol. Cancer 2020, 19, 79. [Google Scholar] [CrossRef] [PubMed]
- de Thé, H. Differentiation Therapy Revisited. Nat. Rev. Cancer 2018, 18, 117–127. [Google Scholar] [CrossRef]
- Fulghieri, P.; Stivala, L.A.; Sottile, V. Modulating Cell Differentiation in Cancer Models. Biochem. Soc. Trans. 2021, 49, 1803–1816. [Google Scholar] [CrossRef]
- Adjiri, A. DNA Mutations May Not Be the Cause of Cancer. Oncol. Ther. 2017, 5, 85–101. [Google Scholar] [CrossRef] [PubMed]
- International Human Genome Sequencing Consortium; Whitehead Institute for Biomedical Research, Center for Genome Research; Lander, E.S.; Linton, L.M.; Birren, B.; Nusbaum, C.; Zody, M.C.; Baldwin, J.; Devon, K.; Dewar, K.; et al. Initial Sequencing and Analysis of the Human Genome. Nature 2001, 409, 860–921. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Cordaux, R.; Batzer, M.A. The Impact of Retrotransposons on Human Genome Evolution. Nat. Rev. Genet. 2009, 10, 691–703. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Ohno, S. So Much “Junk” DNA in Our Genome. Brookhaven Symp. Biol. 1972, 23, 366–370. [Google Scholar]
- Orgel, L.E.; Crick, F.H.C. Selfish DNA: The Ultimate Parasite. Nature 1980, 284, 604–607. [Google Scholar] [CrossRef]
- Goodier, J.L.; Kazazian, H.H. Retrotransposons Revisited: The Restraint and Rehabilitation of Parasites. Cell 2008, 135, 23–35. [Google Scholar] [CrossRef]
- Brouha, B.; Schustak, J.; Badge, R.M.; Lutz-Prigge, S.; Farley, A.H.; Moran, J.V.; Kazazian, H.H. Hot L1s Account for the Bulk of Retrotransposition in the Human Population. Proc. Natl. Acad. Sci. USA 2003, 100, 5280–5285. [Google Scholar] [CrossRef] [Green Version]
- Esnault, C.; Maestre, J.; Heidmann, T. Human LINE Retrotransposons Generate Processed Pseudogenes. Nat. Genet. 2000, 24, 363–367. [Google Scholar] [CrossRef]
- Wei, W.; Gilbert, N.; Ooi, S.L.; Lawler, J.F.; Ostertag, E.M.; Kazazian, H.H.; Boeke, J.D.; Moran, J.V. Human L1 Retrotransposition: Cis Preference versus Trans Complementation. Mol. Cell. Biol. 2001, 21, 1429–1439. [Google Scholar] [CrossRef] [Green Version]
- Kulpa, D.A.; Moran, J.V. Cis-Preferential LINE-1 Reverse Transcriptase Activity in Ribonucleoprotein Particles. Nat. Struct. Mol. Biol. 2006, 13, 655–660. [Google Scholar] [CrossRef]
- Pink, R.C.; Wicks, K.; Caley, D.P.; Punch, E.K.; Jacobs, L.; Francisco Carter, D.R. Pseudogenes: Pseudo-Functional or Key Regulators in Health and Disease? RNA 2011, 17, 792–798. [Google Scholar] [CrossRef] [Green Version]
- Hancks, D.C.; Kazazian, H.H. Active Human Retrotransposons: Variation and Disease. Curr. Opin. Genet. Dev. 2012, 22, 191–203. [Google Scholar] [CrossRef] [Green Version]
- Payer, L.M.; Burns, K.H. Transposable Elements in Human Genetic Disease. Nat. Rev. Genet. 2019, 20, 760–772. [Google Scholar] [CrossRef] [PubMed]
- Gorbunova, V.; Seluanov, A.; Mita, P.; McKerrow, W.; Fenyö, D.; Boeke, J.D.; Linker, S.B.; Gage, F.H.; Kreiling, J.A.; Petrashen, A.P.; et al. The Role of Retrotransposable Elements in Ageing and Age-Associated Diseases. Nature 2021, 596, 43–53. [Google Scholar] [CrossRef] [PubMed]
- Bhat, A.; Ghatage, T.; Bhan, S.; Lahane, G.P.; Dhar, A.; Kumar, R.; Pandita, R.K.; Bhat, K.M.; Ramos, K.S.; Pandita, T.K. Role of Transposable Elements in Genome Stability: Implications for Health and Disease. Int. J. Mol. Sci. 2022, 23, 7802. [Google Scholar] [CrossRef] [PubMed]
- Temin, H.M. The Protovirus Hypothesis: Speculations on the Significance of RNA-Directed DNA Synthesis for Normal Development and for Carcinogenesis. J. Natl. Cancer Inst. 1971, 46, 3–7. [Google Scholar] [PubMed]
- Kiessling, A.A.; Goulian, M. Detection of Reverse Transcriptase Activity in Human Cells. Cancer Res. 1979, 39, 2062–2069. [Google Scholar] [PubMed]
- Ardeljan, D.; Taylor, M.S.; Ting, D.T.; Burns, K.H. The Human Long Interspersed Element-1 Retrotransposon: An Emerging Biomarker of Neoplasia. Clin. Chem. 2017, 63, 816–822. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Lee, E.; Iskow, R.; Yang, L.; Gokcumen, O.; Haseley, P.; Luquette, L.J.; Lohr, J.G.; Harris, C.C.; Ding, L.; Wilson, R.K.; et al. Landscape of Somatic Retrotransposition in Human Cancers. Science 2012, 337, 967–971. [Google Scholar] [CrossRef] [Green Version]
- Burns, K.H. Transposable Elements in Cancer. Nat. Rev. Cancer 2017, 17, 415–424. [Google Scholar] [CrossRef]
- Howard, G.; Eiges, R.; Gaudet, F.; Jaenisch, R.; Eden, A. Activation and Transposition of Endogenous Retroviral Elements in Hypomethylation Induced Tumors in Mice. Oncogene 2008, 27, 404–408. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Nishiyama, A.; Nakanishi, M. Navigating the DNA Methylation Landscape of Cancer. Trends Genet. 2021, 37, 1012–1027. [Google Scholar] [CrossRef] [PubMed]
- Scott, E.C.; Gardner, E.J.; Masood, A.; Chuang, N.T.; Vertino, P.M.; Devine, S.E. A Hot L1 Retrotransposon Evades Somatic Repression and Initiates Human Colorectal Cancer. Genome Res. 2016, 26, 745–755. [Google Scholar] [CrossRef] [Green Version]
- Guy, C.T.; Cardiff, R.D.; Muller, W.J. Induction of Mammary Tumors by Expression of Polyomavirus Middle T Oncogene: A Transgenic Mouse Model for Metastatic Disease. Mol. Cell. Biol. 1992, 12, 954–961. [Google Scholar] [CrossRef]
- Gualtieri, A.; Andreola, F.; Sciamanna, I.; Sinibaldi-Vallebona, P.; Serafino, A.; Spadafora, C. Increased Expression and Copy Number Amplification of LINE-1 and SINE B1 Retrotransposable Elements in Murine Mammary Carcinoma Progression. Oncotarget 2013, 4, 1882–1893. [Google Scholar] [CrossRef] [Green Version]
- Hagan, C.R.; Rudin, C.M. Mobile Genetic Element Activation and Genotoxic Cancer Therapy: Potential Clinical Implications. Am. J. Pharm. 2002, 2, 25–35. [Google Scholar] [CrossRef]
- Terasaki, N.; Goodier, J.L.; Cheung, L.E.; Wang, Y.J.; Kajikawa, M.; Kazazian, H.H.; Okada, N. In Vitro Screening for Compounds That Enhance Human L1 Mobilization. PLoS ONE 2013, 8, e74629. [Google Scholar] [CrossRef] [Green Version]
- Belancio, V.P.; Roy-Engel, A.M.; Deininger, P.L. All y’all Need to Know ‘bout Retroelements in Cancer. Semin. Cancer Biol. 2010, 20, 200–210. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Anwar, S.; Wulaningsih, W.; Lehmann, U. Transposable Elements in Human Cancer: Causes and Consequences of Deregulation. Int. J. Mol. Sci. 2017, 18, 974. [Google Scholar] [CrossRef] [Green Version]
- Mangiacasale, R.; Pittoggi, C.; Sciamanna, I.; Careddu, A.; Mattei, E.; Lorenzini, R.; Travaglini, L.; Landriscina, M.; Barone, C.; Nervi, C.; et al. Exposure of Normal and Transformed Cells to Nevirapine, a Reverse Transcriptase Inhibitor, Reduces Cell Growth and Promotes Differentiation. Oncogene 2003, 22, 2750–2761. [Google Scholar] [CrossRef] [Green Version]
- Landriscina, M.; Fabiano, A.; Altamura, S.; Bagalà, C.; Piscazzi, A.; Cassano, A.; Spadafora, C.; Giorgino, F.; Barone, C.; Cignarelli, M. Reverse Transcriptase Inhibitors Down-Regulate Cell Proliferation in Vitro and in Vivo and Restore Thyrotropin Signaling and Iodine Uptake in Human Thyroid Anaplastic Carcinoma. J. Clin. Endocrinol. Metab. 2005, 90, 5663–5671. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Sciamanna, I.; Landriscina, M.; Pittoggi, C.; Quirino, M.; Mearelli, C.; Beraldi, R.; Mattei, E.; Serafino, A.; Cassano, A.; Sinibaldi-Vallebona, P.; et al. Inhibition of Endogenous Reverse Transcriptase Antagonizes Human Tumor Growth. Oncogene 2005, 24, 3923–3931. [Google Scholar] [CrossRef] [Green Version]
- Dong, J.J.; Zhou, Y.; Liu, Y.T.; Zhang, Z.W.; Zhou, X.J.; Wang, H.J.; Liao, L. In Vitro Evaluation of the Therapeutic Potential of Nevirapine in Treatment of Human Thyroid Anaplastic Carcinoma. Mol. Cell. Endocrinol. 2013, 370, 113–118. [Google Scholar] [CrossRef] [PubMed]
- Hecht, M.; Harrer, T.; Büttner, M.; Schwegler, M.; Erber, S.; Fietkau, R.; Distel, L.V. Cytotoxic Effect of Efavirenz Is Selective against Cancer Cells and Associated with the Cannabinoid System. AIDS 2013, 27, 2031–2040. [Google Scholar] [CrossRef] [PubMed]
- Patnala, R.; Lee, S.-H.; Dahlstrom, J.E.; Ohms, S.; Chen, L.; Dheen, S.T.; Rangasamy, D. Inhibition of LINE-1 Retrotransposon-Encoded Reverse Transcriptase Modulates the Expression of Cell Differentiation Genes in Breast Cancer Cells. Breast Cancer Res. Treat. 2014, 143, 239–253. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Brüning, A.; Jückstock, J.; Kost, B.; Tsikouras, P.; Weissenbacher, T.; Mahner, S.; Mylonas, I. Induction of DNA Damage and Apoptosis in Human Leukemia Cells by Efavirenz. Oncol. Rep. 2017, 37, 617–621. [Google Scholar] [CrossRef]
- Liu, W.; Song, X.; Zhao, S.; He, M.; Wang, H.; Chen, Z.; Xiang, W.; Yi, G.; Qi, S.; Liu, Y. Antitumor Activity and Mechanism of a Reverse Transcriptase Inhibitor, Dapivirine, in Glioblastoma. J. Cancer 2018, 9, 117–128. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Schneider, M.; Buzdin, A.; Weber, A.; Clavien, P.-A.; Borger, P. Combination of Antiretroviral Drugs Zidovudine and Efavirenz Impairs Tumor Growths in a Mouse Model of Cancer. Viruses 2021, 13, 2396. [Google Scholar] [CrossRef] [PubMed]
- Hecht, M.; Erber, S.; Harrer, T.; Klinker, H.; Roth, T.; Parsch, H.; Fiebig, N.; Fietkau, R.; Distel, L.V. Efavirenz Has the Highest Anti-Proliferative Effect of Non-Nucleoside Reverse Transcriptase Inhibitors against Pancreatic Cancer Cells. PLoS ONE 2015, 10, e0130277. [Google Scholar] [CrossRef]
- Houédé, N.; Pulido, M.; Mourey, L.; Joly, F.; Ferrero, J.-M.; Bellera, C.; Priou, F.; Lalet, C.; Laroche-Clary, A.; Raffin, M.C.; et al. A Phase II Trial Evaluating the Efficacy and Safety of Efavirenz in Metastatic Castration-Resistant Prostate Cancer. Oncologist 2014, 19, 1227–1228. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Houede, N.; Piazza, P.V.; Pourquier, P. LINE-1 as a Therapeutic Target for Castration-Resistant Prostate Cancer. Front. Biosci. 2018, 23, 1292–1309. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Tirelli, U.; Bernardi, D.; Spina, M.; Vaccher, E. AIDS-Related Tumors: Integrating Antiviral and Anticancer Therapy. Crit. Rev. Oncol./Hematol. 2002, 41, 299–315. [Google Scholar] [CrossRef]
- Laurence, J. Impact of HAART on HIV-Linked Malignancies. AIDS Read 2003, 13, 202–205. [Google Scholar]
- Cheung, T.W. AIDS-Related Cancer in the Era of Highly Active Antiretroviral Therapy (HAART): A Model of the Interplay of the Immune System, Virus, and Cancer. “On the Offensive—The Trojan Horse Is Being Destroyed”—Part B: Malignant Lymphoma. Cancer Investig. 2004, 22, 787–798. [Google Scholar] [CrossRef]
- Diamond, C.; Taylor, T.H.; Aboumrad, T.; Anton-Culver, H. Changes in Acquired Immunodeficiency Syndrome-Related Non-Hodgkin Lymphoma in the Era of Highly Active Antiretroviral Therapy: Incidence, Presentation, Treatment, and Survival. Cancer 2006, 106, 128–135. [Google Scholar] [CrossRef]
- Mai, A.; Artico, M.; Sbardella, G.; Massa, S.; Novellino, E.; Greco, G.; Loi, A.G.; Tramontano, E.; Marongiu, M.E.; La Colla, P. 5-Alkyl-2-(Alkylthio)-6-(2,6-Dihalophenylmethyl)-3,4-Dihydropyrimidin-4(3H)-Ones: Novel Potent and Selective Dihydro-Alkoxy-Benzyl-Oxopyrimidine Derivatives. J. Med. Chem. 1999, 42, 619–627. [Google Scholar] [CrossRef]
- Sbardella, G.; Bartolini, S.; Castellano, S.; Artico, M.; Paesano, N.; Rotili, D.; Spadafora, C.; Mai, A. 6-Alkylthio-4-[1-(2,6-Difluorophenyl)Alkyl]-1H-[1,3,5]Triazin-2-Ones (ADATs): Novel Regulators of Cell Differentiation and Proliferation. ChemMedChem 2006, 1, 1073–1080. [Google Scholar] [CrossRef] [PubMed]
- Sbardella, G.; Mai, A.; Bartolini, S.; Castellano, S.; Cirilli, R.; Rotili, D.; Milite, C.; Santoriello, M.; Orlando, S.; Sciamanna, I.; et al. Modulation of Cell Differentiation, Proliferation, and Tumor Growth by Dihydrobenzyloxopyrimidine Non-Nucleoside Reverse Transcriptase Inhibitors. J. Med. Chem. 2011, 54, 5927–5936. [Google Scholar] [CrossRef] [PubMed]
- Oricchio, E.; Sciamanna, I.; Beraldi, R.; Tolstonog, G.V.; Schumann, G.G.; Spadafora, C. Distinct Roles for LINE-1 and HERV-K Retroelements in Cell Proliferation, Differentiation and Tumor Progression. Oncogene 2007, 26, 4226–4233. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Carlini, F.; Ridolfi, B.; Molinari, A.; Parisi, C.; Bozzuto, G.; Toccacieli, L.; Formisano, G.; De Orsi, D.; Paradisi, S.; Grober, O.M.V.; et al. The Reverse Transcription Inhibitor Abacavir Shows Anticancer Activity in Prostate Cancer Cell Lines. PLoS ONE 2010, 5, e14221. [Google Scholar] [CrossRef]
- Aschacher, T.; Sampl, S.; Käser, L.; Bernhard, D.; Spittler, A.; Holzmann, K.; Bergmann, M. The Combined Use of Known Antiviral Reverse Transcriptase Inhibitors AZT and DDI Induce Anticancer Effects at Low Concentrations. Neoplasia 2012, 14, 44–53. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Sciamanna, I.; Gualtieri, A.; Cossetti, C.; Osimo, E.F.; Ferracin, M.; Macchia, G.; Aricò, E.; Prosseda, G.; Vitullo, P.; Misteli, T.; et al. A Tumor-Promoting Mechanism Mediated by Retrotransposon-Encoded Reverse Transcriptase Is Active in Human Transformed Cell Lines. Oncotarget 2013, 4, 2271–2287. [Google Scholar] [CrossRef] [Green Version]
- Piriyapongsa, J.; Mariño-Ramírez, L.; Jordan, I.K. Origin and Evolution of Human MicroRNAs From Transposable Elements. Genetics 2007, 176, 1323–1337. [Google Scholar] [CrossRef] [Green Version]
- Lee, H.-E.; Huh, J.-W.; Kim, H.-S. Bioinformatics Analysis of Evolution and Human Disease Related Transposable Element-Derived MicroRNAs. Life 2020, 10, 95. [Google Scholar] [CrossRef]
- Bellisai, C.; Sciamanna, I.; Rovella, P.; Giovannini, D.; Baranzini, M.; Pugliese, G.M.; Zeya Ansari, M.S.; Milite, C.; Sinibaldi-Vallebona, P.; Cirilli, R.; et al. Reverse Transcriptase Inhibitors Promote the Remodelling of Nuclear Architecture and Induce Autophagy in Prostate Cancer Cells. Cancer Lett. 2020, 478, 133–145. [Google Scholar] [CrossRef]
- Briand, N.; Collas, P. Lamina-Associated Domains: Peripheral Matters and Internal Affairs. Genome Biol. 2020, 21, 85. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Nazer, E. To Be or Not Be (in the LAD): Emerging Roles of Lamin Proteins in Transcriptional Regulation. Biochem. Soc. Trans. 2022, 50, 1035–1044. [Google Scholar] [CrossRef]
- Soares, M.L.; Edwards, C.A.; Dearden, F.L.; Ferrón, S.R.; Curran, S.; Corish, J.A.; Rancourt, R.C.; Allen, S.E.; Charalambous, M.; Ferguson-Smith, M.A.; et al. Targeted Deletion of a 170-Kb Cluster of LINE-1 Repeats and Implications for Regional Control. Genome Res. 2018, 28, 345–356. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Vazquez, B.N.; Thackray, J.K.; Simonet, N.G.; Chahar, S.; Kane-Goldsmith, N.; Newkirk, S.J.; Lee, S.; Xing, J.; Verzi, M.P.; An, W.; et al. SIRT7 Mediates L1 Elements Transcriptional Repression and Their Association with the Nuclear Lamina. Nucleic Acids Res. 2019, 47, 7870–7885. [Google Scholar] [CrossRef] [Green Version]
- Guerreiro, I.; Kind, J. Spatial Chromatin Organization and Gene Regulation at the Nuclear Lamina. Curr. Opin. Genet. Dev. 2019, 55, 19–25. [Google Scholar] [CrossRef] [PubMed]
- Della Valle, F.; Reddy, P.; Yamamoto, M.; Liu, P.; Saera-Vila, A.; Bensaddek, D.; Zhang, H.; Prieto Martinez, J.; Abassi, L.; Celii, M.; et al. LINE-1 RNA Causes Heterochromatin Erosion and Is a Target for Amelioration of Senescent Phenotypes in Progeroid Syndromes. Sci. Transl. Med. 2022, 14, eabl6057. [Google Scholar] [CrossRef]
- Cheney, L.; Barbaro, J.M.; Berman, J.W. Antiretroviral Drugs Impact Autophagy with Toxic Outcomes. Cells 2021, 10, 909. [Google Scholar] [CrossRef]
- Zhang, D.; Tang, B.; Xie, X.; Xiao, Y.-F.; Yang, S.-M.; Zhang, J.-W. The Interplay between DNA Repair and Autophagy in Cancer Therapy. Cancer Biol. Ther. 2015, 16, 1005–1013. [Google Scholar] [CrossRef]
- Juretschke, T.; Beli, P. Causes and Consequences of DNA Damage-Induced Autophagy. Matrix Biol. 2021, 100, 39–53. [Google Scholar] [CrossRef]
- Guo, H.; Chitiprolu, M.; Gagnon, D.; Meng, L.; Perez-Iratxeta, C.; Lagace, D.; Gibbings, D. Autophagy Supports Genomic Stability by Degrading Retrotransposon RNA. Nat. Commun. 2014, 5, 5276. [Google Scholar] [CrossRef] [Green Version]
- Chen, Q.; Kang, J.; Fu, C. The Independence of and Associations among Apoptosis, Autophagy, and Necrosis. Sig. Transduct. Target. Ther. 2018, 3, 18. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Thomas, C.A.; Paquola, A.C.M.; Muotri, A.R. LINE-1 Retrotransposition in the Nervous System. Annu. Rev. Cell Dev. Biol. 2012, 28, 555–573. [Google Scholar] [CrossRef]
- Meacham, C.E.; Morrison, S.J. Tumour Heterogeneity and Cancer Cell Plasticity. Nature 2013, 501, 328–337. [Google Scholar] [CrossRef] [Green Version]
- Biswas, A.; De, S. Drivers of Dynamic Intratumor Heterogeneity and Phenotypic Plasticity. Am. J. Physiol.-Cell Physiol. 2021, 320, C750–C760. [Google Scholar] [CrossRef] [PubMed]
- Sciamanna, I.; De Luca, C.; Spadafora, C. The Reverse Transcriptase Encoded by LINE-1 Retrotransposons in the Genesis, Progression, and Therapy of Cancer. Front. Chem. 2016, 4, 6. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Sottoriva, A.; Kang, H.; Ma, Z.; Graham, T.A.; Salomon, M.P.; Zhao, J.; Marjoram, P.; Siegmund, K.; Press, M.F.; Shibata, D.; et al. A Big Bang Model of Human Colorectal Tumor Growth. Nat. Genet. 2015, 47, 209–216. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Kaur, J.; Daoud, A.; Eblen, S.T. Targeting Chromatin Remodeling for Cancer Therapy. Curr. Mol. Pharmacol. 2019, 12, 215–229. [Google Scholar] [CrossRef]
- Lee, S.-C.; Xu, X.; Lim, Y.-W.; Iau, P.; Sukri, N.; Lim, S.-E.; Yap, H.L.; Yeo, W.-L.; Tan, P.; Tan, S.-H.; et al. Chemotherapy-Induced Tumor Gene Expression Changes in Human Breast Cancers. Pharm. Genom. 2009, 19, 181–192. [Google Scholar] [CrossRef]
- Davey, M.G.; Lowery, A.J.; Miller, N.; Kerin, M.J. MicroRNA Expression Profiles and Breast Cancer Chemotherapy. Int. J. Mol. Sci. 2021, 22, 10812. [Google Scholar] [CrossRef]
- Álvarez-Arenas, A.; Podolski-Renic, A.; Belmonte-Beitia, J.; Pesic, M.; Calvo, G.F. Interplay of Darwinian Selection, Lamarckian Induction and Microvesicle Transfer on Drug Resistance in Cancer. Sci. Rep. 2019, 9, 9332. [Google Scholar] [CrossRef] [Green Version]
- Easwaran, H.; Tsai, H.-C.; Baylin, S.B. Cancer Epigenetics: Tumor Heterogeneity, Plasticity of Stem-like States, and Drug Resistance. Mol. Cell 2014, 54, 716–727. [Google Scholar] [CrossRef] [Green Version]
- Pisco, A.O.; Huang, S. Non-Genetic Cancer Cell Plasticity and Therapy-Induced Stemness in Tumour Relapse: ‘What Does Not Kill Me Strengthens Me’. Br. J. Cancer 2015, 112, 1725–1732. [Google Scholar] [CrossRef] [PubMed]
- Salgia, R.; Kulkarni, P. The Genetic/Non-Genetic Duality of Drug ‘Resistance’ in Cancer. Trends Cancer 2018, 4, 110–118. [Google Scholar] [CrossRef] [PubMed]
- Househam, J.; Heide, T.; Cresswell, G.D.; Spiteri, I.; Kimberley, C.; Zapata, L.; Lynn, C.; James, C.; Mossner, M.; Fernandez-Mateos, J.; et al. Phenotypic Plasticity and Genetic Control in Colorectal Cancer Evolution. Nature 2022. [Google Scholar] [CrossRef] [PubMed]
- Heide, T.; Househam, J.; Cresswell, G.D.; Spiteri, I.; Lynn, C.; Mossner, M.; Kimberley, C.; Fernandez-Mateos, J.; Chen, B.; Zapata, L.; et al. The Co-Evolution of the Genome and Epigenome in Colorectal Cancer. Nature 2022. [Google Scholar] [CrossRef] [PubMed]
- Spadafora, C. A LINE-1-Encoded Reverse Transcriptase-Dependent Regulatory Mechanism Is Active in Embryogenesis and Tumorigenesis: Reverse Transcriptase in Embryogenesis and Cancer. Ann. N. Y. Acad. Sci. 2015, 1341, 164–171. [Google Scholar] [CrossRef]
- Virchow, R.L.K. Cellular Pathology, 1859 Special ed.; John Churchill: London, UK, 1978; p. 204. [Google Scholar] [CrossRef] [Green Version]
- Monk, M.; Holding, C. Human Embryonic Genes Re-Expressed in Cancer Cells. Oncogene 2001, 20, 8085–8091. [Google Scholar] [CrossRef] [Green Version]
- Kaiser, S.; Park, Y.-K.; Franklin, J.L.; Halberg, R.B.; Yu, M.; Jessen, W.J.; Freudenberg, J.; Chen, X.; Haigis, K.; Jegga, A.G.; et al. Transcriptional Recapitulation and Subversion of Embryonic Colon Development by Mouse Colon Tumor Models and Human Colon Cancer. Genome Biol. 2007, 8, R131. [Google Scholar] [CrossRef] [Green Version]
- Ma, Y.; Zhang, P.; Wang, F.; Yang, J.; Yang, Z.; Qin, H. The Relationship between Early Embryo Development and Tumourigenesis. J. Cell. Mol. Med. 2010, 14, 2697–2701. [Google Scholar] [CrossRef] [Green Version]
- Lee, M.Y. Embryonic Programs in Cancer and Metastasis—Insights From the Mammary Gland. Front. Cell Dev. Biol. 2022, 10, 938625. [Google Scholar] [CrossRef]
- Hill, C.S. Establishment and Interpretation of NODAL and BMP Signaling Gradients in Early Vertebrate Development. In Current Topics in Developmental Biology; Elsevier: Amsterdam, The Netherlands, 2022; Volume 149, pp. 311–340. ISBN 978-0-12-817097-7. [Google Scholar]
- Bodenstine, T.M.; Chandler, G.S.; Seftor, R.E.B.; Seftor, E.A.; Hendrix, M.J.C. Plasticity Underlies Tumor Progression: Role of Nodal Signaling. Cancer Metastasis Rev. 2016, 35, 21–39. [Google Scholar] [CrossRef] [PubMed]
- Kalyan, A.; Carneiro, B.A.; Chandra, S.; Kaplan, J.; Chae, Y.K.; Matsangou, M.; Hendrix, M.J.C.; Giles, F. Nodal Signaling as a Developmental Therapeutics Target in Oncology. Mol. Cancer Ther. 2017, 16, 787–792. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Waddington, C.H. Canalization of Development and Genetic Assimilation of Acquired Characters. Nature 1959, 183, 1654–1655. [Google Scholar] [CrossRef] [PubMed]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Lavia, P.; Sciamanna, I.; Spadafora, C. An Epigenetic LINE-1-Based Mechanism in Cancer. Int. J. Mol. Sci. 2022, 23, 14610. https://0-doi-org.brum.beds.ac.uk/10.3390/ijms232314610
Lavia P, Sciamanna I, Spadafora C. An Epigenetic LINE-1-Based Mechanism in Cancer. International Journal of Molecular Sciences. 2022; 23(23):14610. https://0-doi-org.brum.beds.ac.uk/10.3390/ijms232314610
Chicago/Turabian StyleLavia, Patrizia, Ilaria Sciamanna, and Corrado Spadafora. 2022. "An Epigenetic LINE-1-Based Mechanism in Cancer" International Journal of Molecular Sciences 23, no. 23: 14610. https://0-doi-org.brum.beds.ac.uk/10.3390/ijms232314610